erythrosine has been researched along with Breast Neoplasms in 100 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Breast Neoplasms: Tumors or cancer of the human BREAST.
Excerpt | Relevance | Reference |
---|---|---|
" In this work, an endogenous ligand, estrone, was used to synthesize doxorubicin-encapsulating liposomes for estrogen receptor (ER)-positive breast cancer therapy with cyanuric chloride (2,4,6 trichloro-1,3,5 triazine) being used as a linking molecule to attach 3-OH group of estrone to the surface of liposomes." | 7.88 | Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy. ( Al Sayah, M; Husseini, GA; Kawak, P; Martins, AM; Paul, V; Salkho, NM; Vitor, RF, 2018) |
" In this work, an endogenous ligand, estrone, was used to synthesize doxorubicin-encapsulating liposomes for estrogen receptor (ER)-positive breast cancer therapy with cyanuric chloride (2,4,6 trichloro-1,3,5 triazine) being used as a linking molecule to attach 3-OH group of estrone to the surface of liposomes." | 3.88 | Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy. ( Al Sayah, M; Husseini, GA; Kawak, P; Martins, AM; Paul, V; Salkho, NM; Vitor, RF, 2018) |
"Fluorescein-labeled dextrans (FITC-D) from 3 to 5000 kDa (Stokes' radii from 1 to 40 nm) were used to study influx from the plasma into the peritoneum and efflux from the peritoneal cavity into the plasma in normal and ascites tumor-bearing mice and in mice whose peritoneal vessels had been rendered hyperpermeable by serotonin." | 3.67 | Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice. ( Dvorak, HF; Herzberg, KT; Masse, EM; Nagy, JA; Zientara, GP, 1989) |
"Breast cancer specimens from 184 patients were analyzed for estrogen binding by two different histochemical techniques using conjugates of estradiol, bovine serum albumin, and fluorescein." | 3.67 | Heterogeneity of estrogen binding sites in breast cancer: morphologic demonstration and relationship to endocrine response. ( Carter, AC; Eisenberg, KB; Feldman, JG; Pertschuk, LP, 1985) |
"Breast cancer is a devastating disease, with different types of breast cancer recurring locally or distant as metastatic/advanced disease following initial treatment." | 1.51 | A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer. ( Brutkiewicz, RR; Liu, J; Seki, T; Tsuji, M, 2019) |
"Breast and cervical cancer cells that stably expressed apoptotic sensor proteins were used to determine apoptosis in real-time by fluorescence resonance energy transfer (FRET)-based imaging microscopy." | 1.48 | Fluidic shear stress increases the anti-cancer effects of ROS-generating drugs in circulating tumor cells. ( Fung, TS; Lim, S; Luo, KQ; Regmi, S, 2018) |
"In vitro studies with MDA-MB-231-LM2 breast cancer cell line showed significant cell killing upon treatment of cell-liposome suspensions with the laser." | 1.42 | Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts. ( Blumenthal, R; Charron, H; Joshi, A; Puri, A; Schiff, R; Sine, J; Tata, DB; Thayer, D; Urban, C; Valim, N, 2015) |
"In Akt-hyperactive cancer, TopBP1 forms oligomers and represses E2F1-dependent apoptosis." | 1.40 | Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy. ( Chowdhury, P; Lin, FT; Lin, GE; Lin, WC; Liu, K; Song, Y, 2014) |
"Breast cancer is the leading cause of cancer deaths among non-smoking women worldwide." | 1.35 | Viability analysis and apoptosis induction of breast cancer cells in a microfluidic device: effect of cytostatic drugs. ( Andersson, H; Franke, HR; Komen, J; van den Berg, A; Vermes, I; Wolbers, F, 2008) |
"One of the major clinical problems in breast cancer detection is the relatively high incidence of occult lymph node metastases undetectable by standard procedures." | 1.35 | Intracellular esterase activity in living cells may distinguish between metastatic and tumor-free lymph nodes. ( Afrimzon, E; Deutsch, A; Deutsch, M; Pappo, I; Sandbank, J; Shafran, Y; Zurgil, N, 2008) |
"Efflux transporters, p-glycoprotein and breast cancer resistance protein (BCRP), located at barrier sites such as the blood-brain barrier may affect distribution of steroids used for treating chronic inflammatory conditions and thus the extent to which they may perturb the hypothalamic-pituitary-adrenal axis." | 1.33 | Modulation of p-glycoprotein and breast cancer resistance protein by some prescribed corticosteroids. ( Barrand, MA; Cahn, AP; Cooray, HC; Hladky, SB; Shahi, S; van Veen, HW, 2006) |
"Screening on MDA-MB-435 breast carcinoma xenografts yielded multiple copies of a phage that displays a cyclic 9-amino-acid peptide, LyP-1." | 1.31 | A tumor-homing peptide with a targeting specificity related to lymphatic vessels. ( Hoffman, JA; Laakkonen, P; Porkka, K; Ruoslahti, E, 2002) |
"Sixty-nine patients with invasive breast cancer underwent subcutaneous mastectomy and immediate reconstruction with a subcutaneously placed prosthesis." | 1.29 | Influence of the site of skin incision on the circulation in the nipple-areola complex after subcutaneous mastectomy in breast cancer. ( Perbeck, LG; Proano, E, 1996) |
"Neoplastic cells of both mammary and extramammary Paget's disease showed cytoplasmic staining with both lectins." | 1.27 | Lectin-binding sites in Paget's disease. ( Furue, M; Hino, H; Ohara, K; Tamaki, K, 1985) |
"Cell surface glycoconjugates of human breast cancer tissue were investigated using FITC peanut (PNA), wheat germ (WGA) and jackbean (concanavalin A; Con A) agglutinins." | 1.27 | Lectin binding in human breast cancer: clinical and pathologic correlations with fluorescein-conjugated peanut, wheat germ and concanavalin A binding. ( Bezwoda, WR; Dansey, R; Murray, J; Ninin, D, 1988) |
" FCM quantification of E-BSA-FITC binding intensity demonstrates a saturable dose-response that is specifically reduced in the presence of diethylstilbestrol (DES) in doses known to saturate Type I ER." | 1.27 | Flow cytometric analysis of fluorescein-conjugated estradiol (E-BSA-FITC) binding in breast cancer suspensions. ( Benz, C; Lee, SH; Wiznitzer, I, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 39 (39.00) | 18.7374 |
1990's | 16 (16.00) | 18.2507 |
2000's | 19 (19.00) | 29.6817 |
2010's | 21 (21.00) | 24.3611 |
2020's | 5 (5.00) | 2.80 |
Authors | Studies |
---|---|
Mukundan, S | 1 |
Bell, J | 1 |
Teryek, M | 1 |
Hernandez, C | 1 |
Love, AC | 1 |
Parekkadan, B | 1 |
Chan, LL | 1 |
Melling, GE | 1 |
Conlon, R | 1 |
Pantazi, P | 1 |
Dellar, ER | 1 |
Samuel, P | 1 |
Baena-Lopez, LA | 1 |
Simpson, JC | 1 |
Carter, DRF | 1 |
Hübner, C | 1 |
Keil, C | 1 |
Jürgensen, A | 1 |
Barthel, L | 1 |
Haase, H | 1 |
Zhou, X | 1 |
Ding, G | 1 |
Fang, Q | 1 |
Guo, J | 1 |
Yang, L | 2 |
Wang, P | 1 |
Fu, SZ | 1 |
Li, A | 1 |
Xia, J | 2 |
Yu, J | 1 |
Ma, M | 1 |
Hu, Z | 1 |
Huang, L | 1 |
Liu, R | 1 |
Jiang, C | 1 |
Li, S | 1 |
Yu, M | 1 |
Xu, X | 1 |
Zhao, Y | 1 |
Hu, Q | 1 |
Xing, W | 1 |
Zhao, Z | 1 |
Fawzy, MS | 1 |
Ashour, H | 1 |
Shafie, AAA | 1 |
Dahman, NBH | 1 |
Fares, AM | 1 |
Antar, S | 1 |
Elnoby, AS | 1 |
Fouad, FM | 1 |
Devine, LD | 1 |
Gallagher, AM | 1 |
Briggs, S | 1 |
Hill, AJ | 1 |
Stopyra, W | 1 |
Alacamli, G | 1 |
Kaderli, ST | 1 |
Edebali, S | 1 |
Alacamli, OG | 1 |
Sul, S | 1 |
Canbek, TD | 1 |
Karalezli, A | 1 |
Stoicescu, EA | 1 |
Cherecheanu, AP | 1 |
Bostan, M | 1 |
Pîrvulescu, R | 1 |
Tiu, C | 1 |
Bujor, I | 1 |
Popa-Cherecheanu, A | 1 |
Balogun, MM | 1 |
Fashola, MB | 1 |
Shi, X | 1 |
Yu, X | 1 |
Duan, X | 1 |
Vandestienne, M | 1 |
Braik, R | 1 |
Lavillegrand, JR | 1 |
Hariri, G | 1 |
Demailly, Z | 1 |
Ben Hamouda, N | 1 |
Tamion, F | 1 |
Clavier, T | 1 |
Ait-Oufella, H | 1 |
Bampidis, V | 1 |
Azimonti, G | 1 |
Bastos, ML | 1 |
Christensen, H | 1 |
Durjava, M | 1 |
Kouba, M | 1 |
López-Alonso, M | 1 |
López Puente, S | 1 |
Marcon, F | 1 |
Mayo, B | 1 |
Pechová, A | 1 |
Petkova, M | 1 |
Ramos, F | 1 |
Sanz, Y | 1 |
Villa, RE | 1 |
Woutersen, R | 1 |
Brantom, P | 1 |
Chesson, A | 1 |
Westendorf, J | 1 |
Manini, P | 1 |
Dusemund, B | 1 |
Bickel Haase, T | 1 |
Naumann-Gola, S | 1 |
Ortner, E | 1 |
Zorn, H | 1 |
Schweiggert-Weisz, U | 1 |
Yang, N | 1 |
Gao, J | 1 |
Han, Y | 1 |
Zhang, L | 1 |
Furusawa, S | 1 |
Ikeda, M | 1 |
Ide, T | 1 |
Kanamura, T | 1 |
Miyamoto, HD | 1 |
Abe, K | 1 |
Ishimaru, K | 1 |
Watanabe, M | 1 |
Tsutsui, Y | 1 |
Miyake, R | 1 |
Fujita, S | 1 |
Tohyama, T | 1 |
Matsushima, S | 1 |
Baba, Y | 1 |
Tsutsui, H | 1 |
Dani, S | 1 |
Kumar, R | 1 |
Sharma, H | 1 |
Choudhary, RJ | 1 |
Goyal, N | 1 |
Kaur, P | 1 |
Pandit, R | 1 |
Pang, Y | 1 |
Bjornsson, R | 1 |
Chung, HR | 1 |
Miller, JE | 1 |
Suh, JD | 1 |
Margolis, G | 1 |
Hamuda, N | 1 |
Kobo, O | 1 |
Elbaz Greener, G | 1 |
Amir, O | 1 |
Homoud, M | 1 |
Madias, C | 1 |
Heist, EK | 1 |
Ruskin, JN | 1 |
Kazatsker, M | 1 |
Roguin, A | 1 |
Leshem, E | 1 |
Rozen, G | 1 |
Elamir, A | 1 |
Ajith, S | 1 |
Sawaftah, NA | 1 |
Abuwatfa, W | 1 |
Mukhopadhyay, D | 2 |
Paul, V | 3 |
Al-Sayah, MH | 2 |
Awad, N | 1 |
Husseini, GA | 3 |
Salkho, NM | 1 |
Kawak, P | 1 |
Vitor, RF | 1 |
Martins, AM | 1 |
Al Sayah, M | 1 |
Klein, S | 1 |
Kızaloğlu, M | 1 |
Portilla, L | 1 |
Park, H | 1 |
Rejek, T | 1 |
Hümmer, J | 1 |
Meyer, K | 1 |
Hock, R | 1 |
Distel, LVR | 1 |
Halik, M | 1 |
Kryschi, C | 1 |
Regmi, S | 1 |
Fung, TS | 1 |
Lim, S | 1 |
Luo, KQ | 1 |
Seki, T | 1 |
Liu, J | 1 |
Brutkiewicz, RR | 1 |
Tsuji, M | 1 |
Awad, NS | 1 |
Rengan, AK | 1 |
Jagtap, M | 1 |
De, A | 1 |
Banerjee, R | 1 |
Srivastava, R | 1 |
Zhang, P | 1 |
Lock, LL | 1 |
Cheetham, AG | 1 |
Cui, H | 1 |
Chowdhury, P | 1 |
Lin, GE | 1 |
Liu, K | 1 |
Song, Y | 1 |
Lin, FT | 1 |
Lin, WC | 1 |
Maeda, A | 1 |
Bu, J | 1 |
Chen, J | 1 |
Zheng, G | 1 |
DaCosta, RS | 1 |
Sine, J | 1 |
Urban, C | 1 |
Thayer, D | 1 |
Charron, H | 1 |
Valim, N | 1 |
Tata, DB | 1 |
Schiff, R | 1 |
Blumenthal, R | 1 |
Joshi, A | 1 |
Puri, A | 1 |
Abbasi, AZ | 1 |
Prasad, P | 1 |
Cai, P | 1 |
He, C | 1 |
Foltz, WD | 1 |
Amini, MA | 1 |
Gordijo, CR | 1 |
Rauth, AM | 1 |
Wu, XY | 1 |
Khosroshahi, ME | 1 |
Hassannejad, Z | 1 |
Firouzi, M | 1 |
Arshi, AR | 1 |
Kuznetsov, AV | 1 |
Javadov, S | 1 |
Saks, V | 1 |
Margreiter, R | 1 |
Grimm, M | 1 |
Zhang, Z | 1 |
Jiao, Y | 1 |
Zhu, M | 1 |
Zhang, S | 1 |
Komen, J | 1 |
Wolbers, F | 1 |
Franke, HR | 1 |
Andersson, H | 1 |
Vermes, I | 1 |
van den Berg, A | 1 |
Sim, HM | 1 |
Lee, CY | 1 |
Ee, PL | 1 |
Go, ML | 1 |
Blokh, D | 1 |
Stambler, I | 1 |
Afrimzon, E | 2 |
Platkov, M | 1 |
Shafran, Y | 2 |
Korech, E | 1 |
Sandbank, J | 2 |
Zurgil, N | 2 |
Deutsch, M | 2 |
Banerjee, J | 1 |
Hanson, AJ | 1 |
Gadam, B | 1 |
Elegbede, AI | 1 |
Tobwala, S | 1 |
Ganguly, B | 1 |
Wagh, AV | 1 |
Muhonen, WW | 1 |
Law, B | 1 |
Shabb, JB | 1 |
Srivastava, DK | 1 |
Mallik, S | 1 |
Shishido, T | 1 |
Mieda, H | 1 |
Hwang, SY | 1 |
Nishimura, Y | 1 |
Tanaka, T | 1 |
Ogino, C | 1 |
Fukuda, H | 1 |
Kondo, A | 1 |
Pasquier, J | 1 |
Magal, P | 1 |
Boulangé-Lecomte, C | 1 |
Webb, G | 1 |
Le Foll, F | 1 |
Qin, G | 1 |
Li, Z | 1 |
Xia, R | 1 |
Li, F | 1 |
O'Neill, BE | 1 |
Goodwin, JT | 1 |
Khant, HA | 1 |
Chiu, W | 1 |
Li, KC | 1 |
Shieh, MJ | 1 |
Hsu, CY | 1 |
Huang, LY | 1 |
Chen, HY | 1 |
Huang, FH | 1 |
Lai, PS | 1 |
Goldenbogen, B | 1 |
Brodersen, N | 1 |
Gramatica, A | 1 |
Loew, M | 1 |
Liebscher, J | 1 |
Herrmann, A | 1 |
Egger, H | 1 |
Budde, B | 1 |
Arbuzova, A | 1 |
Srinivas, P | 1 |
Patra, CR | 1 |
Bhattacharya, S | 1 |
Kullberg, M | 1 |
Mann, K | 1 |
Anchordoquy, TJ | 1 |
Shingu, K | 1 |
Kruschinski, C | 1 |
Lührmann, A | 1 |
Grote, K | 1 |
Tschernig, T | 1 |
Von Hörsten, S | 1 |
Pabst, R | 1 |
Torchilin, VP | 1 |
Lukyanov, AN | 1 |
Gao, Z | 1 |
Papahadjopoulos-Sternberg, B | 1 |
DANIEL BEK, KV | 1 |
Wan, XS | 1 |
Zhou, Z | 1 |
Kennedy, AR | 1 |
Angelini, A | 1 |
Di Febbo, C | 1 |
Ciofani, G | 1 |
Di Nisio, M | 1 |
Baccante, G | 1 |
Di Ilio, C | 1 |
Cuccurullo, F | 1 |
Porreca, E | 1 |
Lin, PH | 2 |
Pan, WC | 1 |
Kang, YW | 1 |
Chen, YL | 1 |
Lin, CH | 2 |
Lee, MC | 1 |
Chou, YH | 1 |
Nakamura, J | 1 |
Viola-Rhenals, M | 1 |
Rieber, MS | 1 |
Rieber, M | 1 |
Cooray, HC | 1 |
Shahi, S | 1 |
Cahn, AP | 1 |
van Veen, HW | 1 |
Hladky, SB | 1 |
Barrand, MA | 1 |
Deutsch, A | 1 |
Pappo, I | 1 |
Stevens, N | 1 |
O'Connor, N | 1 |
Vishwasrao, H | 1 |
Samaroo, D | 1 |
Kandel, ER | 1 |
Akins, DL | 1 |
Drain, CM | 1 |
Turro, NJ | 1 |
Harner, RE | 1 |
Smith, JL | 1 |
Reynolds, DH | 1 |
Nishiki, M | 1 |
Amano, K | 1 |
Yamane, M | 1 |
Okumichi, T | 1 |
Ezaki, H | 1 |
van Marle, J | 2 |
Lindeman, J | 2 |
Ariens, AT | 1 |
Labruyère, W | 1 |
van Weeren-Kramer, J | 1 |
Meijer, CJ | 1 |
Persijn, JP | 1 |
van Niewenhuizen, W | 1 |
Baak, JP | 1 |
Boon, ME | 1 |
Jetha, N | 1 |
Godolphin, W | 1 |
O'Connell, MD | 1 |
Said, JW | 1 |
Uriel, J | 1 |
Failly-Crepin, C | 1 |
Villacampa, MJ | 1 |
Pineiro, A | 1 |
Geuskens, M | 1 |
Walker, RA | 1 |
Furnival, CM | 1 |
Chong, KC | 1 |
Watson, LR | 1 |
Visona, A | 1 |
Louis, CJ | 2 |
Sztynda, T | 1 |
Cheng, ZM | 1 |
Wyllie, RG | 2 |
McCarty, KS | 2 |
Hiatt, KB | 1 |
Budwit, DA | 1 |
Cox, EB | 1 |
Leight, G | 1 |
Reintgen, D | 1 |
Georgiade, G | 1 |
Siegler, HF | 1 |
Lonsdorfer, M | 1 |
Clements, NC | 1 |
Wittliff, JL | 1 |
Oxenhandler, RW | 1 |
McCune, R | 1 |
Subtelney, A | 1 |
Truelove, C | 1 |
Tyrer, HW | 1 |
Fisher, B | 1 |
Gunduz, N | 2 |
Zheng, S | 1 |
Saffer, EA | 1 |
Hanna, W | 1 |
Ryder, DE | 1 |
Mobbs, BG | 1 |
Penney, GC | 1 |
Hawkins, RA | 1 |
Barrows, GH | 1 |
Stroupe, SB | 1 |
Riehm, JD | 1 |
Nenci, I | 1 |
Dandliker, WB | 1 |
Meyers, CY | 1 |
Marchetti, E | 1 |
Marzola, A | 1 |
Fabris, G | 1 |
Price, EA | 1 |
Coombe, DR | 1 |
Murray, JC | 1 |
Hedley, DW | 1 |
Chow, S | 1 |
Goré, J | 1 |
Besson, P | 1 |
Hoinard, C | 1 |
Bougnoux, P | 1 |
Proano, E | 1 |
Perbeck, LG | 1 |
Chan, SD | 1 |
Dill, K | 1 |
Blomdahl, J | 1 |
Wada, HG | 1 |
Van Heusden, J | 1 |
de Jong, P | 1 |
Ramaekers, F | 1 |
Bruwiere, H | 1 |
Borgers, M | 1 |
Smets, G | 1 |
Gelmini, S | 1 |
Orlando, C | 1 |
Sestini, R | 1 |
Vona, G | 1 |
Pinzani, P | 1 |
Ruocco, L | 1 |
Pazzagli, M | 1 |
Stein, U | 1 |
Walther, W | 1 |
Wendt, J | 1 |
Schild, TA | 1 |
Lee, AH | 1 |
Tannock, IF | 1 |
Whitcombe, D | 1 |
Brownie, J | 1 |
Gillard, HL | 1 |
McKechnie, D | 1 |
Theaker, J | 1 |
Newton, CR | 1 |
Little, S | 1 |
Nordström, T | 1 |
Knekt, M | 1 |
Nordström, E | 1 |
Lindqvist, C | 1 |
Shammas, FV | 1 |
Van Eekelen, JA | 1 |
Wee, L | 1 |
Heikkilä, R | 1 |
Osland, A | 1 |
Kolárová, H | 1 |
Kotala, L | 1 |
Strnad, M | 1 |
Bancírová, M | 1 |
Lasovský, J | 1 |
Ambrozová, P | 1 |
Rust, WL | 1 |
Huff, JL | 1 |
Plopper, GE | 1 |
Hildenbrand, R | 1 |
Leitz, M | 1 |
Magdolen, V | 1 |
Luther, T | 1 |
Albrecht, S | 1 |
Graeff, H | 1 |
Stutte, HJ | 1 |
Bleyl, U | 1 |
Schmitt, M | 1 |
Chandel, NS | 1 |
Vander Heiden, MG | 1 |
Thompson, CB | 1 |
Schumacker, PT | 1 |
Zeisig, R | 1 |
Müller, K | 1 |
Maurer, N | 1 |
Arndt, D | 1 |
Fahr, A | 1 |
Laakkonen, P | 1 |
Porkka, K | 1 |
Hoffman, JA | 1 |
Ruoslahti, E | 1 |
Lee, SH | 2 |
Loewenstein, WR | 1 |
Zhang, RD | 1 |
Price, JE | 1 |
Fujimaki, T | 1 |
Bucana, CD | 1 |
Fidler, IJ | 1 |
Krogerus, L | 1 |
Andersson, LC | 1 |
Yamaguchi, Y | 1 |
Toge, T | 1 |
Baba, N | 1 |
Kuninobu, H | 1 |
Kegoya, Y | 1 |
Takayama, T | 1 |
Hattori, T | 1 |
Remmele, W | 1 |
Hildebrand, U | 1 |
Hienz, HA | 1 |
Klein, PJ | 1 |
Vierbuchen, M | 1 |
Behnken, LJ | 1 |
Heicke, B | 1 |
Scheidt, E | 1 |
Nagy, JA | 1 |
Herzberg, KT | 1 |
Masse, EM | 1 |
Zientara, GP | 1 |
Dvorak, HF | 1 |
Daxenbichler, G | 1 |
Dürken, M | 1 |
Marth, C | 1 |
Böck, G | 1 |
Dapunt, O | 1 |
Tamaki, K | 1 |
Hino, H | 1 |
Ohara, K | 1 |
Furue, M | 1 |
De Potter, CR | 1 |
Eechaute, W | 1 |
Roels, H | 1 |
Leusen, I | 1 |
Berthois, Y | 1 |
Pourreau-Schneider, N | 1 |
Gandilhon, P | 1 |
Mittre, H | 1 |
Tubiana, N | 1 |
Martin, PM | 1 |
Avner, B | 1 |
Avner, BP | 1 |
Gaydos, B | 1 |
Liao, SK | 1 |
Thurman, GB | 1 |
Oldham, RK | 1 |
Dansey, R | 1 |
Murray, J | 1 |
Ninin, D | 1 |
Bezwoda, WR | 1 |
Ashcroft, RG | 1 |
Pertschuk, LP | 1 |
Eisenberg, KB | 1 |
Carter, AC | 1 |
Feldman, JG | 1 |
Benz, C | 1 |
Wiznitzer, I | 1 |
Archer, FL | 1 |
Kao, VC | 1 |
Waghe, M | 1 |
Kumar, S | 1 |
Steward, JK | 1 |
Myers, MB | 1 |
Brock, D | 1 |
Cohn, I | 1 |
Karel, I | 1 |
Peleska, M | 1 |
Nagel, GA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Phase II Study of Eribulin in Brain Metastases From HER2-negative Breast Cancer Pre-treated With Anthracyclines and Taxanes[NCT03637868] | Phase 2 | 0 participants (Actual) | Interventional | 2019-02-26 | Withdrawn (stopped due to no enrollment) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for erythrosine and Breast Neoplasms
Article | Year |
---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasm | 2022 |
Junctional intercellular communication and the control of growth.
Topics: Animals; Breast Neoplasms; Calcium; Carcinoma, Hepatocellular; Cell Communication; Cell Count; Cell | 1979 |
1 trial available for erythrosine and Breast Neoplasms
Article | Year |
---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasm | 2022 |
98 other studies available for erythrosine and Breast Neoplasms
Article | Year |
---|---|
Automated Assessment of Cancer Drug Efficacy On Breast Tumor Spheroids in Aggrewell™400 Plates Using Image Cytometry.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Fluoresceins; Fluorescent Dyes; High-Thro | 2022 |
Confocal microscopy analysis reveals that only a small proportion of extracellular vesicles are successfully labelled with commonly utilised staining methods.
Topics: Breast Neoplasms; Dextrans; Extracellular Vesicles; Female; Fluoresceins; Fluorescent Dyes; HeLa Cel | 2022 |
Comparison of Three Low-Molecular-Weight Fluorescent Probes for Measuring Free Zinc Levels in Cultured Mammary Cells.
Topics: Breast Neoplasms; Cells, Cultured; Chelating Agents; Female; Fluoresceins; Fluorescent Dyes; Humans; | 2023 |
Ultrasound-triggered herceptin liposomes for breast cancer therapy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug | 2021 |
Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy.
Topics: Biological Transport; Breast Neoplasms; Doxorubicin; Drug Liberation; Estrogens; Estrone; Fluorescei | 2018 |
Enhanced In Vitro Biocompatibility and Water Dispersibility of Magnetite and Cobalt Ferrite Nanoparticles Employed as ROS Formation Enhancer in Radiation Cancer Therapy.
Topics: Biocompatible Materials; Breast Neoplasms; Cell Survival; Cobalt; Dynamic Light Scattering; Female; | 2018 |
Fluidic shear stress increases the anti-cancer effects of ROS-generating drugs in circulating tumor cells.
Topics: Antioxidants; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cisplatin; Doxorubicin; | 2018 |
A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer.
Topics: Animals; Antigens, CD1d; Breast Neoplasms; Cell Line, Tumor; Female; Fluoresceins; Glycolipids; Huma | 2019 |
Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy.
Topics: Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fluoresce | 2019 |
Multifunctional gold coated thermo-sensitive liposomes for multimodal imaging and photo-thermal therapy of breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Contrast Media; Female; Fluoresceins; Gold; Human | 2014 |
Enhanced cellular entry and efficacy of tat conjugates by rational design of the auxiliary segment.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Membrane Permeability; Cell Proliferation; | 2014 |
Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy.
Topics: Animals; Apoptosis; Breast Neoplasms; Carrier Proteins; DNA-Binding Proteins; E2F1 Transcription Fac | 2014 |
Dual in vivo photoacoustic and fluorescence imaging of HER2 expression in breast tumors for diagnosis, margin assessment, and surgical guidance.
Topics: Animals; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Contrast Media; Fema | 2014 |
Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chlorophyll; Drug Liberation; Fe | 2015 |
Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Liberation; Fema | 2015 |
Nanoshell-mediated targeted photothermal therapy of HER2 human breast cancer cells using pulsed and continuous wave lasers: an in vitro study.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Female; Fluoresceins; Fluo | 2015 |
Synchronism in mitochondrial ROS flashes, membrane depolarization and calcium sparks in human carcinoma cells.
Topics: Adenocarcinoma; Antioxidants; Breast Neoplasms; Calcium Signaling; Cell Line, Tumor; Colonic Neoplas | 2017 |
Nuclear-Shell Biopolymers Initiated by Telomere Elongation for Individual Cancer Cell Imaging and Drug Delivery.
Topics: Biopolymers; Breast Neoplasms; Cell Survival; Cells, Cultured; DNA, Neoplasm; Drug Delivery Systems; | 2017 |
Viability analysis and apoptosis induction of breast cancer cells in a microfluidic device: effect of cytostatic drugs.
Topics: Antineoplastic Agents; Apoptosis; Biological Assay; Breast Neoplasms; Cell Line, Tumor; Cell Surviva | 2008 |
Dimethoxyaurones: Potent inhibitors of ABCG2 (breast cancer resistance protein).
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette | 2008 |
Comparative analysis of cell parameter groups for breast cancer detection.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Case-Control Studies; Computational Biology; Compu | 2009 |
Release of liposomal contents by cell-secreted matrix metalloproteinase-9.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Line, Tumor; Colorectal Neoplasms; Female; Fluoresceins; Huma | 2009 |
Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Female; Fluoresceins; Hepatitis B Antigens; Human | 2010 |
Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model.
Topics: Algorithms; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Communic | 2011 |
Partially polymerized liposomes: stable against leakage yet capable of instantaneous release for remote controlled drug delivery.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Aniline Compounds; Biological Availability; Breast Neoplasms; Ce | 2011 |
Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Cell Nu | 2011 |
Reduction-sensitive liposomes from a multifunctional lipid conjugate and natural phospholipids: reduction and release kinetics and cellular uptake.
Topics: Biotin; Breast Neoplasms; Cell Line, Tumor; Disulfides; Doxorubicin; Drug Delivery Systems; Female; | 2011 |
Cytotoxicity of naphthoquinones and their capacity to generate reactive oxygen species is quenched when conjugated with gold nanoparticles.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation | 2011 |
Targeting Her-2+ breast cancer cells with bleomycin immunoliposomes linked to LLO.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bacterial Toxins; | 2012 |
Intratracheal macrophage-activating lipopeptide-2 reduces metastasis in the rat lung.
Topics: Adenocarcinoma; Animals; Bacterial Proteins; Breast Neoplasms; Cell Line; Fluoresceins; Fluorescent | 2003 |
Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.
Topics: Animals; Antibodies; Biological Transport; Breast Neoplasms; Drug Carriers; Drug Design; Female; Flu | 2003 |
[ON THE PRACTICAL VALUE OF THE MACROLUMINESCENCE ANALYSIS IN CANCER SURGERY].
Topics: Breast Neoplasms; Fluoresceins; Humans; Intestinal Neoplasms; Neoplasms; Stomach Neoplasms; Surgical | 1964 |
Adaptation of the dichlorofluorescein assay for detection of radiation-induced oxidative stress in cultured cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Female; Fluoresceins; Fluorescence; Humans; Oxidation-Reduction; | 2003 |
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Cel | 2005 |
Effects of naphthalene quinonoids on the induction of oxidative DNA damage and cytotoxicity in calf thymus DNA and in human cultured cells.
Topics: Aldehydes; Animals; Breast Neoplasms; Cattle; Cell Line, Tumor; Cell Survival; Cells, Cultured; DNA; | 2005 |
Suppression of survival in human SKBR3 breast carcinoma in response to metal-chelator complexes is preferential for copper-dithiocarbamate.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chelating Agents; Copper; | 2006 |
Modulation of p-glycoprotein and breast cancer resistance protein by some prescribed corticosteroids.
Topics: Adenosine Triphosphatases; Adrenal Cortex Hormones; Antibiotics, Antineoplastic; ATP Binding Cassett | 2006 |
Induction of ROS formation, poly(ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells.
Topics: Benzoflavones; Breast Neoplasms; Catalase; Cell Line, Tumor; Cell Survival; Chelating Agents; Cytoch | 2006 |
Intracellular esterase activity in living cells may distinguish between metastatic and tumor-free lymph nodes.
Topics: Aged; Antigen-Presenting Cells; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intr | 2008 |
Two color RNA intercalating probe for cell imaging applications.
Topics: Animals; Breast Neoplasms; Fluoresceins; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; H | 2008 |
Fluorescein fundus study of metastatic breast carcinoma. Following cryohypophysectomy.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Cryosurgery; Eye Neoplasms; Female; Fluoresceins; Fundus Oc | 1967 |
Estrogen receptors in human breast cancer detected by the fluorescent estradiol histochemical and dextran coated charcoal techniques.
Topics: Breast Neoplasms; Charcoal; Dextrans; Double-Blind Method; Estradiol; Female; Fluorescein-5-isothioc | 1984 |
Estrogen receptors in human breast cancer. I. Specificity of the histochemical localization of estrogen receptors using an estrogen-albumin FITC complex.
Topics: Animals; Breast Neoplasms; Cattle; Cell Transformation, Neoplastic; Estrogens; Fluorescein-5-isothio | 1982 |
Estrogen receptors in human breast cancer. II. Correlation between the histochemical method and biochemical assay.
Topics: Adult; Aged; Animals; Breast Neoplasms; Cattle; Cell Transformation, Neoplastic; Epithelium; Estradi | 1982 |
Unable to obtain good correlation.
Topics: Breast Neoplasms; Female; Fluoresceins; Humans; Receptors, Estrogen; Staining and Labeling | 1982 |
Estrogen receptors in carcinoma of the breast. A comparison of the dextran-coated charcoal, immunofluorescent, and immunoperoxidase technics.
Topics: Adult; Aged; Breast Neoplasms; Charcoal; Dextrans; Female; Fluorescein-5-isothiocyanate; Fluorescein | 1983 |
Incorporation of alphafetoprotein by the MCF-7 human breast cancer cell line.
Topics: Albumins; alpha-Fetoproteins; Animals; Autoradiography; Breast Neoplasms; Cell Line; Chickens; Fluor | 1984 |
The binding of fluorescent-labelled concanavalin A to human breast tissue--a marker of differentiation.
Topics: Breast; Breast Neoplasms; Concanavalin A; Female; Fixatives; Fluorescein-5-isothiocyanate; Fluoresce | 1983 |
Fluorescent cytochemical oestrogen receptor assay: is it valid in breast cancer?
Topics: Adsorption; Adult; Aged; Breast Neoplasms; Charcoal; Estradiol; Female; Fluorescein-5-isothiocyanate | 1983 |
Lectin-binding affinities of human breast tumors.
Topics: Breast; Breast Neoplasms; Female; Fibrocystic Breast Disease; Fluorescein-5-isothiocyanate; Fluoresc | 1983 |
Clinical response to hormone therapy correlated with estrogen receptor analyses. Biochemical v histochemical methods.
Topics: Antibodies; Breast Neoplasms; Estradiol; Estrogens; Female; Fluorescein-5-isothiocyanate; Fluorescei | 1984 |
Use of high-performance liquid chromatography in the evaluation of the synthesis and binding of fluorescein linked steroids to estrogen receptors.
Topics: Animals; Breast Neoplasms; Cattle; Chromatography, High Pressure Liquid; Cytosol; Female; Fluorescei | 1983 |
Flow cytometric determination of estrogen receptors in intact cells.
Topics: Breast Neoplasms; Cell Line; Female; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Humans; Hydroco | 1984 |
Fluorescein-concanavalin A conjugates distinguish between normal and malignant human cells: a preliminary report.
Topics: Breast Neoplasms; Concanavalin A; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent An | 1981 |
Fluoresceinated estrone binding by human and mouse breast cancer cells.
Topics: Adult; Aged; Animals; Binding, Competitive; Biopsy, Needle; Breast Neoplasms; Cell Nucleus; Cytoplas | 1982 |
Cellular localization of estrogen binding sites in human breast cancer.
Topics: Breast Neoplasms; Female; Fluoresceins; Histocytochemistry; Humans; Microscopy, Fluorescence; Neopla | 1982 |
Histochemical detection of oestrogen receptors: a progress report.
Topics: Animals; Binding, Competitive; Breast Neoplasms; Estradiol; Female; Fluoresceins; Histocytochemistry | 1982 |
Nuclear uptake of a 17 beta-estradiol-fluorescein derivative as a marker of estrogen dependence.
Topics: Adult; Animals; Breast; Breast Neoplasms; Endometrium; Estradiol; Female; Fluoresceins; Humans; Micr | 1980 |
Estrogen receptor cytochemistry by fluorescent estrogen.
Topics: Animals; Breast; Breast Neoplasms; Cell Line; Estrone; Fluoresceins; Fluorescent Dyes; Histocytochem | 1980 |
A simple fluorometric assay for quantifying the adhesion of tumour cells to endothelial monolayers.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Adhesion; Cell Adhesion Molecules; Cell Communication; Cells, | 1995 |
Evaluation of methods for measuring cellular glutathione content using flow cytometry.
Topics: Animals; Breast Neoplasms; Bridged Bicyclo Compounds; Buthionine Sulfoximine; Carcinoma; Carcinosarc | 1994 |
Na(+)-H+ antiporter activity in relation to membrane fatty acid composition and cell proliferation.
Topics: Acids; Blood; Breast Neoplasms; Cell Division; Cell Membrane; Extracellular Space; Fatty Acids; Fluo | 1994 |
Influence of the site of skin incision on the circulation in the nipple-areola complex after subcutaneous mastectomy in breast cancer.
Topics: Adult; Aged; Breast; Breast Implants; Breast Neoplasms; Dermatologic Surgical Procedures; Female; Fl | 1996 |
Nonisotopic quantitation of mRNA using a novel RNase protection assay: measurement of erbB-2 mRNA in tumor cell lines.
Topics: Actins; Animals; Biotin; Breast Neoplasms; Chemistry Techniques, Analytical; CHO Cells; Cricetinae; | 1996 |
Fluorescein-labeled tyramide strongly enhances the detection of low bromodeoxyuridine incorporation levels.
Topics: Breast Neoplasms; Bromodeoxyuridine; Female; Fluorescein; Fluoresceins; Humans; Immunohistochemistry | 1997 |
Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-erbB-2 oncogene amplification.
Topics: Base Sequence; Breast Neoplasms; DNA-Directed DNA Polymerase; DNA, Neoplasm; Fluoresceins; Fluoresce | 1997 |
In situ RT-PCR using fluorescence-labeled primers.
Topics: Breast Neoplasms; DNA Primers; Fluorescein; Fluoresceins; Fluorescent Dyes; Humans; In Situ Hybridiz | 1997 |
Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells.
Topics: Amiloride; Animals; Antiporters; Bicarbonates; Breast Neoplasms; Chloride-Bicarbonate Antiporters; C | 1998 |
A homogeneous fluorescence assay for PCR amplicons: its application to real-time, single-tube genotyping.
Topics: Alleles; BRCA2 Protein; Breast Neoplasms; Cystic Fibrosis; DNA; DNA, Neoplasm; Factor V; Female; Flu | 1998 |
A microplate-based fluorometric assay for monitoring human cancer cell attachment to cortical bone.
Topics: Animals; Bone Matrix; Bone Neoplasms; Breast Neoplasms; Cattle; Cell Adhesion; Female; Fluoresceins; | 1999 |
Sensitive and quantitative one-step polymerase chain reaction using capillary electrophoresis and fluorescence detection for measuring cytokeratin 19 expression.
Topics: Bone Marrow; Breast Neoplasms; DNA Primers; Electrophoresis, Capillary; Fluoresceins; Fluorescence; | 1999 |
[Fluorescence methods for studying cell damage].
Topics: Breast Neoplasms; Cell Survival; Female; Fluoresceins; Fluorescent Dyes; Humans; Indoles; Isoindoles | 1998 |
Screening assay for promigratory/antimigratory compounds.
Topics: Antineoplastic Agents; Breast Neoplasms; Drug Screening Assays, Antitumor; Fluoresceins; Fluorescent | 2000 |
Validation of immunolocalization of the urokinase receptor expression in ductal carcinoma in situ of the breast: comparison with detection by non-isotopic in-situ hybridization.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibody Specificity; Breast; Breast Neoplas | 2000 |
Redox regulation of p53 during hypoxia.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Acetylcysteine; Animals; Antioxidants; Breast Neop | 2000 |
The composition-dependent presence of free (micellar) alkylphospholipid in liposomal formulations of octadecyl-1,1-dimethyl-piperidino-4-yl-phosphate affects its cytotoxic activity in vitro.
Topics: Breast Neoplasms; Cell Division; Cell Survival; Chemistry, Pharmaceutical; Cholesterol; Ethanolamine | 2001 |
A tumor-homing peptide with a targeting specificity related to lymphatic vessels.
Topics: Animals; Breast Neoplasms; Cell Nucleus; Female; Fluoresceins; Humans; Lymphatic System; Male; Mice; | 2002 |
Cytochemical study of estrogen receptor in human mammary cancer.
Topics: Breast Neoplasms; Chemical Phenomena; Chemistry; Chromatography, Thin Layer; Estradiol; Estrogens; F | 1978 |
Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Cell Membrane; Cell Membrane Permea | 1992 |
Different lectin-binding patterns in primary breast cancers and their metastases.
Topics: Breast Neoplasms; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Glycoconjugates; Hum | 1990 |
The analysis of lymphocyte surface receptors recognized by wheat germ agglutinin for negative regulation of immune responses in cancer patients.
Topics: Antigens, Surface; Breast Neoplasms; Esophageal Neoplasms; Flow Cytometry; Fluorescein-5-isothiocyan | 1990 |
Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer.
Topics: Antibodies, Monoclonal; Breast Neoplasms; Charcoal; Dextrans; Female; Fluorescein-5-isothiocyanate; | 1986 |
Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice.
Topics: Adenocarcinoma; Animals; Ascites; Biological Transport; Breast Neoplasms; Capillary Permeability; De | 1989 |
Influence of steroids and retinoic acid on peanut-lectin binding of human breast cancer cells.
Topics: Breast Neoplasms; Cell Line; Dexamethasone; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Huma | 1986 |
Lectin-binding sites in Paget's disease.
Topics: Apocrine Glands; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Eccrine Glands; | 1985 |
Comparative study between histochemical and biochemical estimation of estrogen receptors in tumors.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Centrifugation, Density Gradient; Cytosol | 1985 |
Estradiol membrane binding sites on human breast cancer cell lines. Use of a fluorescent estradiol conjugate to demonstrate plasma membrane binding systems.
Topics: Binding Sites; Binding, Competitive; Breast Neoplasms; Cell Line; Cell Membrane; Estradiol; Estrogen | 1986 |
Characterization of a method using viable human target cells as the solid phase in a cell concentration fluorescence immunoassay (CCFIA) for screening of monoclonal antibodies and hybridoma supernatants.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Breast Neoplasms; Cell Line; Cell Survival; Cell-Fr | 1988 |
Lectin binding in human breast cancer: clinical and pathologic correlations with fluorescein-conjugated peanut, wheat germ and concanavalin A binding.
Topics: Breast Neoplasms; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Lectins; Middle Aged; | 1988 |
Measurement of ligand binding, E-BSA-FITC.
Topics: Breast Neoplasms; Estradiol; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Serum Albumin, Bovi | 1986 |
Heterogeneity of estrogen binding sites in breast cancer: morphologic demonstration and relationship to endocrine response.
Topics: Binding Sites; Breast Neoplasms; Cell Nucleus; Cytoplasm; Estradiol; Female; Fluorescein; Fluorescei | 1985 |
The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy.
Topics: Antibodies, Monoclonal; Autoradiography; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Fluorescei | 1985 |
Flow cytometric analysis of fluorescein-conjugated estradiol (E-BSA-FITC) binding in breast cancer suspensions.
Topics: Binding, Competitive; Breast Neoplasms; Cell Line; Diethylstilbestrol; Estradiol; Female; Flow Cytom | 1985 |
Immunohistochemical identification of actomyosin in myoepithelium of human tissues.
Topics: Animals; Breast; Breast Neoplasms; Cytoplasm; Epithelial Cells; Epithelium; Female; Fluoresceins; Fl | 1968 |
The lack of effect of mouse epidermal growth factor (EGF) and its anti-serum on human tissues.
Topics: Adenocarcinoma; Animals; Breast; Breast Neoplasms; Culture Techniques; Female; Fluoresceins; Growth | 1973 |
Prevention of skin slough after radical mastectomy by the use of a vital dye to delineate devascularized skin.
Topics: Breast Neoplasms; Fluoresceins; Humans; Mastectomy; Necrosis; Postoperative Complications; Skin; Ski | 1971 |
Fluorescence angiography in intraocular tumours.
Topics: Adenocarcinoma; Breast Neoplasms; Bronchial Neoplasms; Choroid Neoplasms; Diagnosis, Differential; E | 1972 |
[Immunosuppression: a paraneoplastic syndrome].
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Bronchial Neoplasms; Culture Techniques; Cyclophosphamide; | 1971 |